Search

Author/Creator Wranke, A.

1. Interferon‐free therapy of chronic hepatitis C with direct‐acting antivirals does not change the short‐term risk for de novo hepatocellular carcinoma in patients with liver cirrhosis. Issue 4 (4th December 2017)

Authors:
Mettke, F.; Schlevogt, B.; Deterding, K.; Wranke, A.; Smith, A.; Port, K.; Manns, M. P.; Vogel, A.; Cornberg, M.; Wedemeyer, H.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 47:Issue 4(2018)
Page Start:
516
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Risk factors and seroprevalence of hepatitis E evaluated in frozen‐serum samples (2002‐2003) of pregnant women compared with female blood donors in a Southern region of Brazil. Issue 12 (3rd September 2018)

Authors:
Hardtke, S.; Rocco, R.; Ogata, J.; Braga, S.; Barbosa, M.; Wranke, A.; Doi, E.; da Cunha, D.; Maluf, E.; Wedemeyer, H.; Muzzillo, D.
Journal:
Journal of medical virology
Issue:
Volume 90:Issue 12(2018)
Page Start:
1856
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Viral dominance patterns in chronic hepatitis delta determine early response to interferon alpha therapy. Issue 11 (10th July 2018)

Authors:
Lutterkort, G. L.; Wranke, A.; Hengst, J.; Yurdaydin, C.; Stift, J.; Bremer, B.; Hardtke, S.; Keskin, O.; Idilman, R.; Manns, M. P.; Dienes, H. P.; Falk, C.; Wedemeyer, H.; Heidrich, B.
Journal:
Journal of viral hepatitis
Issue:
Volume 25:Issue 11(2018)
Page Start:
1384
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗